Zhengping Xu

12PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersDisease surveillanceMolecular targetsInfectious agentsIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 24, 2026
Ribonuclease 5/Angiogenin Suppresses Intestinal Tumor Initiation by Maintaining Crypt Homeostasis.

Xiaoliang Shi, Jingzhou Chen, Rongpan Bai

|Jan 19, 2026
G9a-mediated H3K9me2 orchestrates intestinal epithelial regeneration through epigenetic silencing of cell cycle-related genes.

Jingzhou Chen, Xiaoliang Shi, Xinyi Zhou

|Dec 09, 2025
G9a epigenetically suppresses CXCL10 expression and inhibits anti-tumor immunity in hepatocellular carcinoma.

Xinxin Chai, Jingzhou Chen, Yuanyuan Zhao

|Jul 10, 2024
Ribonuclease 4 functions as an intestinal antimicrobial protein to maintain gut microbiota and metabolite homeostasis.

Jun Sun, Muxiong Chen, Zhen Hu

|Nov 05, 2022
Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging.

Muxiong Chen, Zhe Feng, Xiaoxiao Fan

|Jun 25, 2022
Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.

Nil Vanli, Jinghao Sheng, Shuping Li

Pageof 2

Frequent Collaborators

7 joint publications

Jinghao Sheng

3 joint publications

Rongpan Bai

2 joint publications

Guo-Fu Hu

1 joint publications

Dongdong Yu